Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer?
Ann Oncol
.
2025 Jan 22:S0923-7534(25)00012-2.
doi: 10.1016/j.annonc.2025.01.008.
Online ahead of print.
Authors
J Remon
1
,
S P L Saw
2
Affiliations
1
Department of Cancer Medicine, Gustave Roussy, Villejuif, France,. Electronic address: JORDI.REMON-MASIP@gustaveroussy.fr.
2
Department of Medical Oncology, National Cancer Centre Singapore, Duke-NUS Oncology Academic Clinical Programme, Singapore.
PMID:
39855428
DOI:
10.1016/j.annonc.2025.01.008
No abstract available
Publication types
Editorial